16:0-22:6 PC
Manufacturer: Sigma Aldrich
CAS Number: 59403-54-2
Synonym(S): 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine; PC(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 850461C-25-MG | In Stock | ₹ 35,488.80 |
850461C - 25 MG
In Stock
Quantity
1
Base Price: ₹ 35,488.80
GST (18%): ₹ 6,387.984
Total Price: ₹ 41,876.784
description
1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine, chloroform
Assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 2.5 mL (850461C-25mg)
manufacturer/tradename
Avanti Polar Lipids
concentration
10 mg/mL (850461C-25mg)
lipid type
cardiolipinsphospholipids
shipped in
dry ice
storage temp.
−20°C
InChI
1S/C46H80NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-19-17-15-13-11-9-7-2/h8,10,14,16,20-21,23-24,27,29,33,35,44H,6-7,9,11-13,15,17-19,22,25-26,28,30-32,34,36-43H2,1-5H3/b10-8-,16-14-,21-20-,24-23-,29-27-,35-33-/t44-/m1/s1
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 59403-54-2 | 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine | A2B Chem | ₹ 7,187.04 - ₹ 21,218.88 |
Related Products
Description
- General description: 16:0-22:6 PC or 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine is a glycerophospholipid, with substitution of palmitic acid and docosahexaenic acid at sn-1 and sn-2 positions of the glycerol backbone, respectively.
- Application: 16:0-22:6 PC or 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine:has been used in vesicle preparation[1]has been used in liposome extrusion and liposome flotation assay[2]might be used in large unilamellar vesicles (LUVs) to develop a scattering density profile (SDP) model for lipids with polyunsaturated fatty acid (PUFA)[3]
- Packaging: 5 mL Clear Glass Sealed Ampule (850461C-25mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
description: 1-palmitoyl-2-docosahexaenoyl-sn-glycero-3-phosphocholine, chloroform
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (850461C-25mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: 10 mg/mL (850461C-25mg)
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C46H80NO8P/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-29-31-33-35-37-39-46(49)55-44(43-54-56(50,51)53-41-40-47(3,4)5)42-52-45(48)38-36-34-32-30-28-26-19-17-15-13-11-9-7-2/h8,10,14,16,20-21,23-24,27,29,33,35,44H,6-7,9,11-13,15,17-19,22,25-26,28,30-32,34,36-43H2,1-5H3/b10-8-,16-14-,21-20-,24-23-,29-27-,35-33-/t44-/m1/s1
description: __
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (850464C-25mg)
manufacturer/tradename: Avanti Polar Lipids 850464C
concentration: 10 mg/mL (850464C-25mg)
lipid type: phospholipidscardiolipins
shipped in: dry ice
storage temp.: −20°C
InChI: __
description: __
Assay: >99% (TLC)
form: liquid
packaging: pkg of 1 × 2.5 mL (850467C-25mg)pkg of 2 × 4 mL (850467C-200mg)
manufacturer/tradename: Avanti Polar Lipids 850467C
concentration: 10 mg/mL (850467C-25mg)25 mg/mL (850467C-200mg)
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
InChI: 1S/C44H86NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-43(46)50-40-42(41-52-54(48,49)51-39-38-45(3,4)5)53-44(47)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h21,23,42H,6-20,22,24-41H2,1-5H3/b23-21-/t42-/m1/s1
